世界の神経痛治療市場2020-2027:治療別(薬物、手術)、エンドユーザー別、地域別

◆英語タイトル:Global Neuralgia Treatment Market Size study, by Treatment (Drug Based, Surgery), by End-User (Hospitals & Clinics, Ambulatory Surgery Center, Others) and Regional Forecasts 2020-2027
◆商品コード:BZW20OC153
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年10月20日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、日本、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥534,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥675,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本市場調査資料では、神経痛治療の世界市場を広く調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、市場分析、治療別(薬物、手術)分析、エンドユーザー別(病院・クリニック、外来手術センター、その他)分析、地域別分析、競争状況、調査プロセスなど、以下の構成でまとめております。

・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・市場分析
・神経痛治療の世界市場規模:治療別(薬物、手術)
・神経痛治療の世界市場規模:エンドユーザー別(病院・クリニック、外来手術センター、その他)
・神経痛治療の世界市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Neuralgia Treatment Market is valued approximately at USD 1.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 6% over the forecast period 2020-2027. Neuralgia is an anomalous symptom which causes intense and mostly severe pain, due to damaged or irritated nerve. Neuralgia treatment procedures are proven to be an effective treatment option, which helps to cure disorders caused by the damages nerve, including diabetes, cardiovascular diseases, and many more. Potential neuralgia treatment methods may include surgery to ease the pressure, regulate sugar level in the blood of diabetic patient, physical therapy, epidural injections to reduce pain, etc., which ultimately expand the scope of neuralgia treatment around the world. Further, the increase in the neuralgia treatment market is significantly imputed to the fact that the presence of better diagnostic criteria options and access to neuralgia treatment service is relentlessly expanding across the globe. Moreover, the rise in prevalence of diabetes and trigeminal neuralgia along with growing geriatric population around the world are the few other factors responsible for the CAGR of the market during the forecast period.

According to the International Diabetic Federation (IDF), there were 463 million adults aged between 20-79 years are living with diabetes in 2019 worldwide, and this prevalence is likely to reach at almost 700 million by the year 2045. Likewise, as per the IDF Diabetes Atlas in 2019, the numbers of diabetic patients in Europe is likely to reach around 68 million by the year 2045, and the total health expenditure for the treatment of diabetes is valued at USD 214 billion. This, in turn, is expected to strengthen the demand for neuralgia treatment, accelerating the market growth all over the world. However, the high cost of the treatment coupled with the lack of skilled healthcare professionals are the few factors restraining the market growth over the forecast period of 2020-2027.

The regional analysis of the global Neuralgia Treatment market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing awareness among people for neuralgia treatment along with the presence of a significant number of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of diabetes and neuralgia disorder followed by the growing aging population in the countries, such as China and India, would create lucrative growth prospects for the Neuralgia Treatment market across the Asia-Pacific region.

Major market player included in this report are:
GlaxoSmithKline PLC
Pfizer Inc.
Novartis AG
Biogen Inc.
Cadila Healthcare Limited
Lundbeck Pharmaceuticals LLC
Allergan Plc
Merz Pharma GmbH & Co.
Trigemina Inc.,
Abbott Laboratories

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment:
Drug Based
Surgery

By End-User:
Hospitals & Clinics
Ambulatory Surgery Center
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Neuralgia Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Neuralgia Treatment Market, by Region, 2018-2027 (USD Billion)
1.2.2. Neuralgia Treatment Market, by Treatment, 2018-2027 (USD Billion)
1.2.3. Neuralgia Treatment Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Neuralgia Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Neuralgia Treatment Market Dynamics
3.1. Neuralgia Treatment Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Neuralgia Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Neuralgia Treatment Market, by Treatment
5.1. Market Snapshot
5.2. Global Neuralgia Treatment Market by Treatment, Performance – Potential Analysis
5.3. Global Neuralgia Treatment Market Estimates & Forecasts by Treatment 2017-2027 (USD Billion)
5.4. Neuralgia Treatment Market, Sub Segment Analysis
5.4.1. Drug Based
5.4.2. Surgery
Chapter 6. Global Neuralgia Treatment Market, by End-User
6.1. Market Snapshot
6.2. Global Neuralgia Treatment Market by End-User – Potential Analysis
6.3. Global Neuralgia Treatment Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
6.4. Neuralgia Treatment Market, Sub Segment Analysis
6.4.1. Hospitals & Clinics
6.4.2. Ambulatory Surgery Center
6.4.3. Others
Chapter 7. Global Neuralgia Treatment Market, Regional Analysis
7.1. Neuralgia Treatment Market, Regional Market Snapshot
7.2. North America Neuralgia Treatment Market
7.2.1. U.S. Neuralgia Treatment Market
7.2.1.1. Treatment breakdown estimates & forecasts, 2017-2027
7.2.1.2. End-User breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Neuralgia Treatment Market
7.3. Europe Neuralgia Treatment Market Snapshot
7.3.1. U.K. Neuralgia Treatment Market
7.3.2. Germany Neuralgia Treatment Market
7.3.3. France Neuralgia Treatment Market
7.3.4. Spain Neuralgia Treatment Market
7.3.5. Italy Neuralgia Treatment Market
7.3.6. Rest of Europe Neuralgia Treatment Market
7.4. Asia-Pacific Neuralgia Treatment Market Snapshot
7.4.1. China Neuralgia Treatment Market
7.4.2. India Neuralgia Treatment Market
7.4.3. Japan Neuralgia Treatment Market
7.4.4. Australia Neuralgia Treatment Market
7.4.5. South Korea Neuralgia Treatment Market
7.4.6. Rest of Asia Pacific Neuralgia Treatment Market
7.5. Latin America Neuralgia Treatment Market Snapshot
7.5.1. Brazil Neuralgia Treatment Market
7.5.2. Mexico Neuralgia Treatment Market
7.6. Rest of The World Neuralgia Treatment Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. GlaxoSmithKline PLC
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Pfizer Inc.
8.2.3. Novartis AG
8.2.4. Biogen Inc.
8.2.5. Cadila Healthcare Limited
8.2.6. Lundbeck Pharmaceuticals LLC
8.2.7. Allergan Plc
8.2.8. Merz Pharma GmbH & Co.
8.2.9. Trigemina Inc.,
8.2.10. Abbott Laboratories
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. Global Neuralgia Treatment market, report scope
TABLE 2. Global Neuralgia Treatment market estimates & forecasts by region 2017-2027 (USD Billion)
TABLE 3. Global Neuralgia Treatment market estimates & forecasts by Treatment 2017-2027 (USD Billion)
TABLE 4. Global Neuralgia Treatment market estimates & forecasts by End-User 2017-2027 (USD Billion)
TABLE 5. Global Neuralgia Treatment market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 6. Global Neuralgia Treatment market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global Neuralgia Treatment market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Neuralgia Treatment market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Neuralgia Treatment market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Neuralgia Treatment market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Neuralgia Treatment market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Neuralgia Treatment market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Neuralgia Treatment market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Neuralgia Treatment market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Neuralgia Treatment market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. Global Neuralgia Treatment market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. Global Neuralgia Treatment market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. Global Neuralgia Treatment market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Global Neuralgia Treatment market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Global Neuralgia Treatment market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 21. U.S. Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. U.S. Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 23. U.S. Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 24. Canada Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 25. Canada Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 26. Canada Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 27. UK Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 28. UK Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 29. UK Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. Germany Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 31. Germany Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 32. Germany Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 33. France Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 34. France Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 35. France Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. Spain Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 37. Spain Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 38. Spain Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. Italy Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 40. Italy Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 41. Italy Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. ROE Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 43. ROE Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 44. ROE Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 45. China Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 46. China Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 47. China Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. India Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 49. India Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 50. India Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. Japan Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 52. Japan Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 53. Japan Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. Australia Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 55. Australia Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 56. Australia Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 57. South Korea Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 58. South Korea Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 59. South Korea Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 60. ROPAC Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 61. ROPAC Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 62. ROPAC Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 63. Brazil Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 64. Brazil Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 65. Brazil Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 66. Mexico Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 67. Mexico Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 68. Mexico Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 69. ROLA Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 70. ROLA Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 71. ROLA Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 72. ROW Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 73. ROW Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 74. ROW Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 75. List of secondary sources, used in the study of global Neuralgia Treatment market
TABLE 76. List of primary sources, used in the study of global Neuralgia Treatment market
TABLE 77. Years considered for the study
TABLE 78. Exchange rates considered

List of figures
FIG 1. Global Neuralgia Treatment market, research methodology
FIG 2. Global Neuralgia Treatment market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Neuralgia Treatment market, key trends 2019
FIG 5. Global Neuralgia Treatment market, growth prospects 2020-2027
FIG 6. Global Neuralgia Treatment market, porters 5 force Model
FIG 7. Global Neuralgia Treatment market, pest analysis
FIG 8. Global Neuralgia Treatment market, value chain analysis
FIG 9. Global Neuralgia Treatment market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Neuralgia Treatment market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Neuralgia Treatment market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Neuralgia Treatment market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Neuralgia Treatment market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Neuralgia Treatment market by segment, 2017 & 2027 (USD Billion)
FIG 15. Global Neuralgia Treatment market by segment, 2017 & 2027 (USD Billion)
FIG 16. Global Neuralgia Treatment market by segment, 2017 & 2027 (USD Billion)
FIG 17. Global Neuralgia Treatment market, regional snapshot 2017 & 2027
FIG 18. North America Neuralgia Treatment market 2017 & 2027 (USD Billion)
FIG 19. Europe Neuralgia Treatment market 2017 & 2027 (USD Billion)
FIG 20. Asia-Pacific Neuralgia Treatment market 2017 & 2027 (USD Billion)
FIG 21. Latin America Neuralgia Treatment market 2017 & 2027 (USD Billion)
FIG 22. Global Neuralgia Treatment market, company market share analysis (2019)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の神経痛治療市場2020-2027:治療別(薬物、手術)、エンドユーザー別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆